241 filings
8-K
CTSO
Cytosorbents Corp
9 May 24
CytoSorbents Reports First Quarter 2024 Results
5:23pm
8-K
CTSO
Cytosorbents Corp
6 May 24
Amendments to Articles of Incorporation or Bylaws
5:00pm
8-K
CTSO
Cytosorbents Corp
3 Apr 24
Departure of Directors or Certain Officers
6:06am
8-K
CTSO
Cytosorbents Corp
14 Mar 24
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
8:55pm
8-K
CTSO
Cytosorbents Corp
17 Jan 24
Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients
5:20pm
8-K
x776n7
28 Dec 23
CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation
4:49pm
8-K
riemwfv
13 Dec 23
CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering
9:15am
8-K
rtl aafz766fd5m55h
11 Dec 23
Entry into a Material Definitive Agreement
4:10pm
8-K
dkrjkx86nqterg00c
9 Nov 23
CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
4:20pm
8-K
8rw98o0u4lv52t15nk4
27 Sep 23
Other Events
8:15am
8-K
ume5nf6m0jo79qkv
19 Sep 23
CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer
4:30pm
8-K
y7kh iywika
12 Sep 23
Other Events
4:31pm
8-K
7tapdhz4clp4
1 Sep 23
CytoSorbents Announces Resignation of Chief Financial Officer Alexander D’Amico
4:30pm
8-K
ep0iuoxzkk7 unfcx5
11 Aug 23
Regulation FD Disclosure
5:30pm
8-K
zxl415ihd bfv940jlg6
2 Aug 23
CytoSorbents Reports Second Quarter 2023 Financial and Operational Results
12:00am
8-K
p0atw
19 Jul 23
CytoSorbents Appoints Alexander D’Amico as Chief Financial Officer
5:19pm
8-K
45ni1
11 Jul 23
Departure of Directors or Certain Officers
5:21pm
8-K
nigyh3 k9
7 Jul 23
CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial
4:31pm
8-K
r1fep
7 Jun 23
Submission of Matters to a Vote of Security Holders
7:30am
8-K
jnr98jk1n
2 May 23
CytoSorbents Reports First Quarter 2023 Results
5:27pm